FWDIHIGH SIGNALFINANCIAL10-K

FWDI underwent a massive share count increase from 1.1M to 86.5M shares outstanding while experiencing substantial revenue decline and significant balance sheet deleveraging.

The dramatic share dilution suggests a major corporate restructuring, stock split, or financing event that fundamentally altered the company's capital structure. Combined with meaningful revenue contraction and substantial debt reduction, this indicates FWDI is navigating a significant transformation that materially impacts shareholder economics and business scale.

Comparing 2025-12-11 vs 2024-12-27View on EDGAR →
FINANCIAL ANALYSIS

The company's financial profile contracted meaningfully with revenue declining substantially to $18.2M while gross profit showed more resilience, falling modestly to $5.2M. Balance sheet changes were pronounced, with current liabilities and total liabilities declining significantly alongside a major reduction in accounts receivable, suggesting either business downsizing or collection of outstanding receivables. The combination of reduced capital expenditure and stable cash position indicates a more conservative operational stance during this period of transition.

FINANCIAL STATEMENT CHANGES
Current Liabilities
Balance Sheet
-70.9%
$9.4M→$2.7M

Current liabilities reduced — improved short-term financial position and working capital health.

Accounts Receivable
Balance Sheet
-70.8%
$5.6M→$1.6M

Receivables declined — improved collection efficiency or conservative revenue recognition.

Capital Expenditure
Cash Flow
-60.4%
$65K→$26K

Capex reduced 60.4% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Total Liabilities
Balance Sheet
-59.2%
$11.8M→$4.8M

Liabilities reduced 59.2% — deleveraging improves balance sheet strength and financial flexibility.

Inventory
Balance Sheet
+46.5%
$334K→$490K

Inventory surged 46.5% — growing faster than typical sales pace; potential demand softening or supply chain overcorrection.

Revenue
P&L
-39.8%
$30.2M→$18.2M

Revenue declined 39.8% — significant demand weakness or market share loss warrants investigation.

Interest Expense
P&L
-21.6%
$63K→$49K

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

Cash & Equivalents
Balance Sheet
+17.8%
$4.0M→$4.8M

Cash grew 17.8% — improving liquidity position supports investment and shareholder returns.

Gross Profit
P&L
-16.4%
$6.2M→$5.2M

Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.

LANGUAGE CHANGES
NEW — 2025-12-11
PRIOR — 2024-12-27
ADDED
There were 86,459,465 shares of the registrant s common stock outstanding as of December 5, 2025.
Market for Registrant's Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities 31 Item 6.
Management's Discussion and Analysis of Financial Condition and Results of Operations 31 Item 7A.
( Forward US ), DE Sub 1, LLC ( Forward Delaware ), Forward Industries (Switzerland) GmbH ( Forward Switzerland ), Forward Industries UK Limited ( Forward UK ), Intelligent Product Solutions, Inc.
( Kablooe ), is a design company serving top tier medical and technology customers.
The Company provides hardware and software product design and engineering services to customers predominantly located in the U.S.
The Company also acquires and holds Solana ( SOL ) and other digital assets and has adopted SOL as its primary treasury reserve asset.
On November 17, 2025, the Company changed its ticker symbol on the Nasdaq Capital Market from FORD to FWDI.
Our in-house capabilities include the following: Electrical Engineering Mechanical Engineering Software Engineering Industrial Design User Experience/User Interface (UX/UI) Design and Development Optical Engineering Program Management IoT System Architecture IT Support There are very few suppliers required for the design segment of the business as it is a service-based business.
1 New Digital Asset Treasury Strategy In September 2025, we announced the launch of our digital asset treasury strategy, pursuant to which we plan to pursue a number of strategic initiatives to acquire Solana ( SOL ) and other digital assets.
REMOVED
There were 1,101,069 shares of the registrant s common stock outstanding as of December 6, 2024.
Market for Registrant s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities 18 Item 6.
Management s Discussion and Analysis of Financial Condition and Results of Operations 18 Item 7A.
( Forward US ), Forward Industries (Switzerland) GmbH ( Forward Switzerland ), Forward Industries UK Limited ( Forward UK ), Intelligent Product Solutions, Inc.
( Kablooe ), is a global design, sourcing and distribution company serving top tier medical and technology customers worldwide.
The principal customer in our original equipment manufacturer ( OEM ) distribution business has been OEMs or the contract manufacturing firms of these OEM customers, that either package our products as accessories in box together with their branded product offerings or sell them through their retail distribution channels.
Our OEM products include carrying cases and other accessories for medical monitoring and diagnostic kits and a variety of other portable electronic and non-electronic products such as sporting and recreational products, bar code scanners, GPS location devices, tablets and firearms.
We do not manufacture any of our OEM or retail distribution products and source substantially all these products from independent suppliers in China through Forward Industries Asia-Pacific Corporation, a British Virgin Islands corporation ( Forward China ).
Forward China is owned by our Chairman and Chief Executive Officer.
Our design business provides hardware and software product design and engineering services to customers predominantly located in the U.S.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →